A bill to amend 2022 PA 11, entitled “Pharmacy benefit manager licensure and regulation act,” by amending sections 5, 7, and 9 (MCL 550.815, 550.817, and 550.819) and by adding section 10.
Clarifies terms such as "affiliated pharmacy," "specialty drug," and "spread pricing," and introducing definitions for "mail-order pharmacy," "manufacturer," and "network pharmacy." The bill seeks to enhance transparency and oversight in PBM operations, addressing drug utilization review, prior authorization, and pharmacy network management.
Co-sponsored by Reps.
Referred to the Committee on Insurance and Financial Services
